BCAT1 and central nervous system cancer: The results showed that BCAT1 is increasingly expressed in glioma tissues corresponding to increasing tumor grade (Figure 1G), and compared to IDH1 wild-type diffuse glioma patients (Figure 1H), the patients that had gained IDH1 R132H mutation showed a lower percentage of tumor cells with detectable BCAT1 expression.